Thyroid diseases after treatment of Hodgkin's disease

New England Journal of Medicine

Volumn 325, Issue 9, 1991, Pages 599-605

  Hancock, Steven L ^a   Cox, Richard S ^a   Mcdougall, I Ross ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GRAVES DISEASE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THYROID DISEASE; THYROID FOLLICULAR CARCINOMA; THYROTOXICOSIS;

EID: 0025835720     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199108293250902     Document Type: Article

References (48)

1. Groover T.A., Christie A.C., Merritt E.A., Coe F.O., McPeak E.M. Roentgen irradiation in the treatment of hyperthyroidism: a statistical evaluation based on three hundred and five cases. JAMA 1929; 92:1730-4
2. Markson J.L., Flatman G.E. Myxoedema after deep x-ray therapy to the neck. BMJ 1965; 1:1228-30
3. McHardy-Young S., Lessof M.H., Blackburn G., O#x0027;Gorman P. Myxoedema after x-ray therapy to the neck. BMJ 1965; 2:230
4. Einhorn J., Wilkholm G. Hypothyroidism after external irradiation to the thyroid region. Radiology 1967; 88:326-8
5. Glatstein E., McHardy-Young S., Brast N., Eltringham J.R., Kriss J.P. Alterations in serum thyrotropin (TSH) and thyroid function following radiotherapy in patients with malignant lymphoma. J Clin Endocrinol Metab 1971; 32:833-41
6. Shalet S.M., Rosenstock J.D., Beardwell C.G., Pearson D., Jones P.H.M. Thyroid dysfunction following external irradiation to the neck for Hodgkin#x0027;s disease in childhood. Clin Radiol 1977; 28:511-5
7. Nelson D.F., Reddy K.V., O#x0027;Mara R.E., Rubin P. Thyroid abnormalities following neck irradiation for Hodgkin#x0027;s disease. Cancer 1978; 42:2553-62
8. Schimpff S.C., Diggs C.H., Wiswell J.G., Salvatore P.C., Wiemik P.H. Radiation-related thyroid dysfunction: implications for the treatment of Hodgkin#x0027;s disease. Ann Intern Med 1980; 92:91-98
9. Smith R.E. Jr., Adler A.R., Clark P., Brinck-Johnsen T., Tulloh M.E., Colton T. Thyroid function after mantle irradiation in Hodgkin#x0027;s disease. JAMA 1981; 245:46-9
10. Kinsella T.J., Fraass B.A., Glatstein E. Late effects of radiation therapy in the treatment of Hodgkin#x0027;s disease. Cancer Treat Rep 1982; 66:991-1001
11. Mauch P.M., Weinstein H., Botnick L., Belli J., Cassady J.R. An evaluation of long-term survival and treatment complications in children with Hodgkin#x0027;s disease. Cancer 1983; 51:925-32
12. Constine L.S., Donaldson S.S., McDougall I.R., Cox R.S., Link M.P., Kaplan H.S. Thyroid dysfunction after radiotherapy in children with Hodgkin#x0027;s disease. Cancer 1984; 53:878-83
13. Young R.C., Bookman M.A., Longo D.L. Late complications of Hodgkin#x0027;s disease management. In: The lymphomas: current concepts in pathogenesis and management. Journal of the National Cancer Institute monographs. No. 10. Washington, D.C: Government Printing Office, 1990: 55-60. (NIH publication no. 90–1930.)
14. Wasnich R.D., Grumet F.C., Payne R.O., Kriss J.P. Graves#x0027; ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease. J Clin Endocrinol Metab 1973; 37:703-13
15. Pilepich M.V., Jackson I., Munzenrider J.E., Brown R.S. Graves#x0027; disease following irradiation for Hodgkin#x0027;s disease. JAMA 1978; 240:1381-2
16. Jackson R., Rosenberg C., Kleinmann R., Vagenakis A.G., Braverman L.E. Ophthalmopathy after neck irradiation therapy for Hodgkin#x0027;s disease. Cancer Treat Rep 1979; 63:1393-5
17. Jacobson D.R., Fleming B.J. Graves#x0027; disease with ophthalmopathy following radiotherapy for Hodgkin#x0027;s disease. Am J Med Sci 1984; 288:217-20
18. Ghandour C., Le Prise P.Y., Hespel J.P. Hodgkin#x0027;s disease and hyperthyroidism. Acta Haematol (Basel) 1985; 74:137-43
19. Mortimer R.H., Hill G.E., Galligan J.P., Bransden Al, Tyack S.A., Roeser H.P. Hypothyroidism and Graves#x0027; disease after mantle irradiation: a follow up study. AustN ZJ Med 1986; 16:347-51
20. Loeffler J.S., Tarbell N.J., Garber J.R., Mauch P. The development of Graves#x0027; disease following radiation therapy in Hodgkin#x0027;s disease. Int J Radiat Oncol Biol Phys 1988; 14:175-8
21. Porter A.T., Ostrowski M.J. Fluctuating thyroid dysfunction following irra diation of the neck for the treatment of Hodgkin#x0027;s disease. J R Soc Med 1988; 81:45-46
22. Blitzer J.B., Paolozzi F.P., Gottlieb A.J., Zamkoff K.W., Chung C.T. Thyrotoxic thyroiditis after radiotherapy for Hodgkin#x0027;s disease. Arch Intern Med 1985; 145:1734-5
23. Petersen M., Keeling C.A., McDougall I.R. Hyperthyroidism with low radioiodine uptake after head and neck irradiation for Hodgkin#x0027;s disease. J Nucl Med 1989; 30:255-7
24. Meyer O.O. Carcinoma of the thyroid following ionizing radiation for Hodgkin#x0027;s disease. Wis Med J 1971; 70:129-33
25. Weshler Z., Krasnokuki D., Peshin Y., Biran S. Thyroid carcinoma induced by irradiation for Hodgkin#x0027;s disease: report of a case. Acta Radiol Oncol Radiat Phys Biol 1978; 17:383-6
26. McDougall I.R., Coleman C.N., Burke J.S., Saunders W., Kaplan H.S. Thyroid carcinoma after high-dose external radiotherapy for Hodgkin#x0027;s disease: report of three cases. Cancer 1980; 45:2056-60
27. Nicol F., McLaren K.M., Toft A.D. Multifocal follicular carcinoma of thyroid following radiotherapy for Hodgkin#x0027;s disease. Postgrad Med J 1982; 58:180-1
28. Bakri K., Shimaoka K., Rao U., Tsukada Y. Adenosquamous carcinoma of the thyroid after radiotherapy for Hodgkin#x0027;s disease: a case report and review. Cancer 1983; 52:465-70
29. Amin R. Follicular carcinoma of the thyroid following radiotherapy for Hodgkin#x0027;s disease. Br J Radiol 1983; 56:768-9
30. Moroff S.V., Fuks J.Z. Thyroid cancer following radiotherapy for Hodgkin#x0027;s disease: a case report and review of the literature. Med Pediatr Oncol 1986; 14:216-20
31. Tucker M.A., Coleman C.N., Cox R.S., Varghese A., Rosenberg S.A. Risk of second cancers after treatment for Hodgkin#x0027;s disease. N Engl J Med 1988; 318:76-81
32. Storm H.H., Prener A. Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943–80. National Cancer Institute monograph 68. Washington, D.C.: Government Printing Office, 1985: 389-410. (NIH publication no. 85–2714.)
33. Kaldor J.M., Day N.E., Band P., et al. Second malignancies following testicular cancer, ovarian cancer, and Hodgkin#x0027;s disease: an international collaborative study among cancer registries. Int J Cancer 1987; 39:571-85
34. Greene M.H., Wilson J. Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935–82. National Cancer Institute monograph 68. Washington, D.C.: Government Printing Office, 1985: 191-217. (NIH publication no. 85–2714.)
35. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81
36. Gehan E.A. A generalized Wilcoxon test for comparing arbitrarily singlycensored samples. Biometrika 1965; 52:203-23
37. Cox D.R. Regression models and life-tables. J R Stat Soc [B] 1972; 34:187-220
38. Monson R.R. Analysis of relative survival and proportional mortality. Comput Biomed Res 1974; 7:325-32
39. Forty-five years of cancer incidence in Connecticut: 1935–79. National Cancer Institute monograph 70. Washington, D.C.: Government Printing Office, 1986: 84-5. (NIH publication no. 86–2652.)
40. Furszyfer J., Kurland L.T., McConahey W.M., Elveback L.R. Graves#x0027; disease in Olmsted County, Minnesota, 1935 through 1967. Mayo Clin Proc 1970; 45:636-44
41. Berglund J., Christensen S.B., Hallengren B. Total and age-specific incidence of Graves#x0027; thyrotoxicosis, toxic nodular goitre and solitary toxic adenoma in Malmö, 1970–74. J Intern Med 1990; 227:137-41
42. Kaplan M.M., Garnick M.B., Gelber R., et al. Risk factors for thyroid abnormalities after neck irradiation for childhood cancer. Am J Med 1983; 74:272-80
43. Arem R., Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism: effect of levothyroxine therapy. Arch Intern Med 1990; 150:2097-100
44. Series J.J., Biggart E.M., O#x0027;Reilly DStJ, Packard C.J., Shepherd J. Thyroid dysfunction and hypercholesterolaemia in the general population of Glasgow, Scotland. Clin Chim Acta 1988; 172:217-21
45. Dean J.W., Fowler P.B.S. Exaggerated responsiveness to thyrotrophin releasing hormone: a risk factor in women with coronary artery disease. BMJ 1985; 290:1555-61
46. Constine L.S., McDougall I.R. Radiation therapy for Hodgkin#x0027;s disease followed by hypothyroidism and then Graves#x0027; hyperthyroidism. Clin Nucl Med 1982; 7:69-70
47. Marcial-Vega V.A., Order S.E., Lastner G., Cole P.D., LaFrance N., O#x0027;Neill M. Prevention of hypothyroidism related to mantle irradiation for Hodgkin#x0027;s disease: preparative phantom study. Int J Radiat Oncol Biol Phys 1990; 18:613-8
48. Bantle J.P., Lee C.K.K., Levitt S.H. Thyroxine administration during radiation therapy to the neck does not prevent subsequent thyroid dysfunction. Int J Radiat Oncol Biol Phys 1985; 11:1999-2002